Index of reports
> Cases with Chills (12)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Intron A (Interferon Alfa-2B) where reactions include chills. The selected reports were submitted to the FDA during the sample period of about a year.
Possible Intron A side effects in
Reported by a pharmacist from United States on 2012-08-10
Patient:
Reactions: Chills, Tremor
Drug(s) suspected as cause:
Intron A
Possible Intron A side effects in male
Reported by a physician from United States on 2012-07-31
Patient: male, weighing 112.0 kg (246.4 pounds)
Reactions: Weight Decreased, Abdominal Pain, Nausea, Chills, Dysstasia, Fatigue, Diarrhoea, Dehydration, Dizziness, Fluid Intake Reduced
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Intron A
Possible Intron A side effects in male
Reported by a health professional (non-physician/pharmacist) from Australia on 2012-06-22
Patient: male
Reactions: Nausea, Chills, Pain, Radiation Skin Injury, Pyrexia, Treatment Noncompliance, Rash Pruritic, Fatigue, Lymph Node Pain, Liver Function Test Abnormal, Swelling, Asthenia, Lymphoedema, Post Procedural Infection
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Intron A (Interferon Alfa-2B)
Dosage: 40 miu;;iv, 30 miu,,iv,
Indication: Malignant Melanoma
Start date: 2011-11-17
End date: 2011-12-02
Intron A (Interferon Alfa-2B)
Dosage: 40 miu;;iv, 30 miu,,iv,
Indication: Malignant Melanoma
Start date: 2011-11-07
Intron A
Dosage: 20 miu; unk;, 15 miu;tiw;, 10 miu;tiw, 10 miu,tiw;
Indication: Malignant Melanoma
Start date: 2012-01-13
End date: 2012-01-25
Intron A
Dosage: 20 miu; unk;, 15 miu;tiw;, 10 miu;tiw, 10 miu,tiw;
Indication: Malignant Melanoma
Start date: 2012-02-13
Intron A
Dosage: 20 miu; unk;, 15 miu;tiw;, 10 miu;tiw, 10 miu,tiw;
Indication: Malignant Melanoma
Start date: 2011-12-05
Other drugs received by patient: Levothyroxine Sodium
Possible Intron A side effects in female
Reported by a health professional (non-physician/pharmacist) from Australia on 2012-05-23
Patient: female
Reactions: Renal Function Test Abnormal, Food Poisoning, Pain, Chills, Blood Count Abnormal, Headache, Pyrexia, Lower Respiratory Tract Infection, Fatigue, Liver Function Test Abnormal, Feeling of Body Temperature Change, Blood Pressure Abnormal, Blood Creatinine Increased, Lethargy, Blood Test Abnormal, Salmonella Sepsis, Dyspnoea, Cardiac Flutter, Nausea, Rash
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Intron A
Dosage: 40 miu;iv 30 miu;iv 22.6 miu;tiw;iv 22.4 miu;tiw 22.5 miut;tiw
Indication: Malignant Melanoma
Start date: 2011-10-06
End date: 2011-12-01
Intron A
Dosage: 40 miu;iv 30 miu;iv 22.6 miu;tiw;iv 22.4 miu;tiw 22.5 miut;tiw
Indication: Malignant Melanoma
Start date: 2012-01-16
Intron A
Dosage: 40 miu;iv 30 miu;iv 22.6 miu;tiw;iv 22.4 miu;tiw 22.5 miut;tiw
Indication: Malignant Melanoma
Start date: 2011-08-29
Intron A
Dosage: 40 miu;iv 30 miu;iv 22.6 miu;tiw;iv 22.4 miu;tiw 22.5 miut;tiw
Indication: Malignant Melanoma
Start date: 2011-10-03
Intron A
Dosage: 40 miu;iv 30 miu;iv 22.6 miu;tiw;iv 22.4 miu;tiw 22.5 miut;tiw
Indication: Malignant Melanoma
Start date: 2011-10-16
Intron A
Dosage: 40 miu;iv 30 miu;iv 22.6 miu;tiw;iv 22.4 miu;tiw 22.5 miut;tiw
Indication: Malignant Melanoma
Start date: 2012-05-07
Other drugs received by patient: Micardis; Amlodipine Besylate; Amlodipine Besylate; Atiacid; Zofran; Acetaminophen
Possible Intron A side effects in male
Reported by a health professional (non-physician/pharmacist) from Australia on 2012-05-17
Patient: male
Reactions: Nausea, Pain, Chills, Pyrexia, Thermal Burn, Rash Pruritic, Hepatic Enzyme Increased, Asthenia, Lymphoedema, Infection
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Intron A
Dosage: 40 miu; iv, 30 miu; iv, 20 miu, 15 miu;tiw, 10 miu; tiw, 10 miu;tiw
Indication: Malignant Melanoma
Start date: 2011-11-07
Intron A
Dosage: 40 miu; iv, 30 miu; iv, 20 miu, 15 miu;tiw, 10 miu; tiw, 10 miu;tiw
Indication: Malignant Melanoma
Start date: 2011-11-17
End date: 2011-12-02
Intron A
Dosage: 40 miu; iv, 30 miu; iv, 20 miu, 15 miu;tiw, 10 miu; tiw, 10 miu;tiw
Indication: Malignant Melanoma
Start date: 2011-12-05
Intron A
Dosage: 40 miu; iv, 30 miu; iv, 20 miu, 15 miu;tiw, 10 miu; tiw, 10 miu;tiw
Indication: Malignant Melanoma
Start date: 2012-02-13
Intron A
Dosage: 40 miu; iv, 30 miu; iv, 20 miu, 15 miu;tiw, 10 miu; tiw, 10 miu;tiw
Indication: Malignant Melanoma
Start date: 2012-01-13
End date: 2012-01-25
Other drugs received by patient: Levothyroxine Sodium
Possible Intron A side effects in female
Reported by a health professional (non-physician/pharmacist) from Australia on 2012-04-12
Patient: female
Reactions: Salmonella Sepsis, Dyspnoea, Cardiac Flutter, Renal Function Test Abnormal, Nausea, Chills, Food Poisoning, Headache, Rash, Lower Respiratory Tract Infection, Laboratory Test Abnormal, Fatigue, Liver Function Test Abnormal, White Blood Cell Count Increased, Lethargy
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Intron A
Dosage: 40 miu; iv, 30 miu; iv, 22.6 miu; tiw; iv, 22.6 miu; tiw, 22.6 miu; tiw
Indication: Malignant Melanoma
Start date: 2011-10-03
Intron A
Dosage: 40 miu; iv, 30 miu; iv, 22.6 miu; tiw; iv, 22.6 miu; tiw, 22.6 miu; tiw
Indication: Malignant Melanoma
Start date: 2011-10-16
Intron A
Dosage: 40 miu; iv, 30 miu; iv, 22.6 miu; tiw; iv, 22.6 miu; tiw, 22.6 miu; tiw
Indication: Malignant Melanoma
Start date: 2012-01-16
Intron A
Dosage: 40 miu; iv, 30 miu; iv, 22.6 miu; tiw; iv, 22.6 miu; tiw, 22.6 miu; tiw
Indication: Malignant Melanoma
Start date: 2011-08-29
Intron A
Dosage: 40 miu; iv, 30 miu; iv, 22.6 miu; tiw; iv, 22.6 miu; tiw, 22.6 miu; tiw
Indication: Malignant Melanoma
Start date: 2011-10-06
End date: 2011-12-01
Other drugs received by patient: Micardis; Antiacid; Zofran; Acetaminophen
Possible Intron A side effects in male
Reported by a health professional (non-physician/pharmacist) from Australia on 2012-03-02
Patient: male
Reactions: Nausea, Pain, Chills, Radiation Skin Injury, Pyrexia, Thermal Burn, Rash Pruritic, Fatigue, Liver Function Test Abnormal, Asthenia, Post Procedural Infection, Infection
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Intron A
Dosage: 40 miu;iv, 30 miu;iv, 20 miu;unk, 15 miu;tiw, 10 miu;tiw
Indication: Malignant Melanoma
Start date: 2012-02-13
Intron A
Dosage: 40 miu;iv, 30 miu;iv, 20 miu;unk, 15 miu;tiw, 10 miu;tiw
Indication: Malignant Melanoma
Start date: 2011-11-07
Intron A
Dosage: 40 miu;iv, 30 miu;iv, 20 miu;unk, 15 miu;tiw, 10 miu;tiw
Indication: Malignant Melanoma
Start date: 2012-01-13
End date: 2012-01-25
Intron A
Dosage: 40 miu;iv, 30 miu;iv, 20 miu;unk, 15 miu;tiw, 10 miu;tiw
Indication: Malignant Melanoma
Start date: 2011-11-17
End date: 2011-12-02
Intron A
Dosage: 40 miu;iv, 30 miu;iv, 20 miu;unk, 15 miu;tiw, 10 miu;tiw
Indication: Malignant Melanoma
Start date: 2011-12-05
Other drugs received by patient: Levothyroxine Sodium
Possible Intron A side effects in female
Reported by a health professional (non-physician/pharmacist) from Australia on 2012-02-07
Patient: female
Reactions: Dyspnoea, Cardiac Flutter, Nausea, Body Temperature Increased, Chills, Headache, Rash, Lower Respiratory Tract Infection, Fatigue, Liver Function Test Abnormal, Lethargy
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Intron A
Dosage: 40 miu; ;iv 30 miu; ;iv 22.6 miu; ;tiw;iv; 22.6 miu;tiw ; 22.6 miu;tiw
Indication: Malignant Melanoma
Start date: 2011-10-16
Intron A
Dosage: 40 miu; ;iv 30 miu; ;iv 22.6 miu; ;tiw;iv; 22.6 miu;tiw ; 22.6 miu;tiw
Indication: Malignant Melanoma
Start date: 2011-10-06
End date: 2011-12-01
Intron A
Dosage: 40 miu; ;iv 30 miu; ;iv 22.6 miu; ;tiw;iv; 22.6 miu;tiw ; 22.6 miu;tiw
Indication: Malignant Melanoma
Start date: 2012-01-16
Intron A
Dosage: 40 miu; ;iv 30 miu; ;iv 22.6 miu; ;tiw;iv; 22.6 miu;tiw ; 22.6 miu;tiw
Indication: Malignant Melanoma
Start date: 2011-10-03
Intron A
Dosage: 40 miu; ;iv 30 miu; ;iv 22.6 miu; ;tiw;iv; 22.6 miu;tiw ; 22.6 miu;tiw
Indication: Malignant Melanoma
Start date: 2011-08-29
Other drugs received by patient: Micardis; Zofran; Antiacid; Acetaminophen
Possible Intron A side effects in female
Reported by a health professional (non-physician/pharmacist) from Australia on 2011-12-19
Patient: female
Reactions: Dyspnoea, Cardiac Flutter, Nausea, Chills, Headache, Rash, Fatigue, Liver Function Test Abnormal, Lethargy
Drug(s) suspected as cause:
Intron A
Dosage: 40 miu;iv 30 miu;iv 22.6 miu;tiw;iv
Indication: Malignant Melanoma
Start date: 2011-10-16
Intron A
Dosage: 40 miu;iv 30 miu;iv 22.6 miu;tiw;iv
Indication: Malignant Melanoma
Start date: 2011-08-29
Intron A
Dosage: 40 miu;iv 30 miu;iv 22.6 miu;tiw;iv
Indication: Malignant Melanoma
Start date: 2011-10-06
Intron A
Dosage: 40 miu;iv 30 miu;iv 22.6 miu;tiw;iv
Indication: Malignant Melanoma
Start date: 2011-10-03
Other drugs received by patient: Micardis; Zofran; Antacid; Acetaminophen
Possible Intron A side effects in 55 year old male
Reported by a physician from United States on 2011-11-03
Patient: 55 year old male, weighing 59.0 kg (129.7 pounds)
Reactions: Pneumonia, Dyspnoea, Vomiting, Nausea, Chills, Respiratory Distress, Constipation, Chronic Obstructive Pulmonary Disease, Dehydration, Platelet Count Decreased, Crepitations, Dizziness, Gait Disturbance, Asthenia, Blood Glucose Increased, Decreased Appetite, Cough
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Intron A
Dosage: sc
Indication: Hepatitis C
Start date: 2011-01-10
End date: 2011-03-14
Rebetol
Dosage: 1000 mg;qd;po
Administration route: Oral
Indication: Hepatitis C
Start date: 2011-01-10
End date: 2011-04-04
Other drugs received by patient: Catapres-TTS-2; Diflucan; Humulin R / Novolin R; Sodium Chloride; Xanax; Sodium Chloride; Fentanyl / NS; Lantus; Solu-Medrol; Nitroglycerin; Prilosec; Heparin Lock-Flush; Sodium Chloride; Aldactone; Ultram; Doribax; Cordarone; Dextrose; Reglan; Atropine Sulfate; Glucagon; Sodium Chloride; Theophylline; Norvasc; Combivent; Versed; Acetaminophen; Acetaminophen; Tussionex; Albuterol; Heparin Sodium; Protonix; Combivent; Dextrose 50% IN Water
Possible Intron A side effects in female
Reported by a health professional (non-physician/pharmacist) from Australia on 2011-10-31
Patient: female
Reactions: Fatigue, Cardiac Flutter, Body Temperature Increased, Nausea, Chills, Liver Function Test Abnormal, Headache
Drug(s) suspected as cause:
Intron A
Dosage: unk;unk
Indication: Malignant Melanoma
Start date: 2011-10-16
Intron A
Dosage: 40 miu;unk;iv, 30 miu;unk;iv, 22.6 miu;tiw;iv
Indication: Malignant Melanoma
Start date: 2011-10-03
Intron A
Dosage: 40 miu;unk;iv, 30 miu;unk;iv, 22.6 miu;tiw;iv
Indication: Malignant Melanoma
Start date: 2011-08-29
Other drugs received by patient: Zofran; Acetaminophen; Micardis; Antacid
Possible Intron A side effects in 51 year old female
Reported by a health professional (non-physician/pharmacist) from United States on 2011-10-04
Patient: 51 year old female
Reactions: Pancreatitis Acute, Chills, Hyperhidrosis, Pallor, Pancreatitis Necrotising, Glomerulonephritis, Obesity, Chest Pain, Gastrooesophageal Reflux Disease, Renal Failure Acute, Refusal of Treatment by Patient, Type 2 Diabetes Mellitus, Blood Triglycerides Decreased, Hyponatraemia, Haemodialysis, Heart Rate Decreased, Skin Neoplasm Excision, Hypertension, Sleep Apnoea Syndrome, Influenza Like Illness
Adverse event resulted in: hospitalization, disablity
Drug(s) suspected as cause:
Intron A
Dosage: iv; iv
Indication: Malignant Melanoma Stage III
Start date: 2011-03-28
End date: 2011-04-01
Intron A
Dosage: iv; iv
Indication: Malignant Melanoma Stage III
Start date: 2011-03-21
End date: 2011-03-25
Decadron
Other drugs received by patient: Compazine; Hydrochlorothiazide; Aspirin; Percocet; Norvasc
|